Human papillomavirus infection, risk for subsequent development of cervical neoplasia and associated population attributable fraction
Data up to Jan 2025
Total Citations Per Year
Abstract
References (45)
Meta-analysis in clinical trials
1986 • 36,193 citations
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
1999 • 8,737 citations
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
1995 • 8,575 citations
Meta-analysis: Principles and procedures
1997 • 2,277 citations
NATURAL HISTORY OF CERVICOVAGINAL PAPILLOMAVIRUS INFECTION IN YOUNG WOMEN
1998 • 1,885 citations
meta-analysis bias in location and selection of studies
1998 • 1,311 citations
Epidemiologic Evidence Showing That Human Papillomavirus Infection Causes Most Cervical Intraepithelial Neoplasia
1993 • 1,236 citations
Meta-analysis Spurious precision? Meta-analysis of observational studies
1998 • 971 citations
A Cohort Study of the Risk of Cervical Intraepithelial Neoplasia Grade 2 or 3 in Relation to Papillomavirus Infection
1992 • 952 citations
Human Papillomavirus Infection of the Cervix
2021 • 753 citations
Human papillomavirus and cancer: the epidemiological evidence
2000 • 610 citations
Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm
1991 • 585 citations
The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women
1998 • 566 citations
Type-Specific Persistence of Human Papillomavirus DNA before the Development of Invasive Cervical Cancer
1999 • 495 citations
Cancer and infection: estimates of the attributable fraction in 1990.
1997 • 394 citations
Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study
2000 • 371 citations
Attributable risk percent in case-control studies.
1971 • 351 citations
Cancer invasion and tissue remodeling‐cooperation of protease systems and cell types
1999 • 288 citations
Detection of Human Papillomavirus DNA in Cytologically Normal Women and Subsequent Cervical Squamous Intraepithelial Lesions
1999 • 252 citations
PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears
1996 • 231 citations
Effect of grapefruit juice on blood cyclosporin concentration
1995 • 205 citations
Seropositivities to Human Papillomavirus Types 16, 18, or 33 Capsids and to Chlamydia trachomatis Are Markers of Sexual Behavior
1996 • 172 citations
Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study
1996 • 163 citations
Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer
1997 • 138 citations
Serologic Response to Human Papillomavirus Type 16 (HPV-16) Virus-like Particles in HPV-16 DNA-Positive Invasive Cervical Cancer and Cervical Intraepithelial Neoplasia Grade III Patients and Controls from Colombia and Spain
1995 • 124 citations
Association of human papillomavirus type 16 integration in the E2 gene with poor disease‐free survival from cervical cancer
1997 • 111 citations
IgG immune response toHelicobacter pylori antigens in patients with gastric cancer as defined by ELISA and immunoblotting
1996 • 105 citations
Association of human papillomavirus type 16 integration in theE2 gene with poor disease-free survival from cervical cancer
1997 • 94 citations
Immunoglobulin G Responses Against Human Papillomavirus Type 16 Virus-Like Particles in a Prospective Nonintervention Cohort Study of Women With Cervical Intraepithelial Neoplasia
1997 • 93 citations
Persistence of human papillomavirus (HPV) infections preceding cervical carcinoma
1996 • 93 citations
Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction
1996 • 88 citations
Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix
1994 • 86 citations
Antibodies against linear and conformational epitopes of human papillomavirus type 16 that independently associate with incident cervical cancer
1995 • 80 citations
Antibodies to human papillomavirus 16 and subsequent in situ or invasive cancer of the cervix.
1997 • 78 citations
Human papillomavirus in false negative archival cervical smears: implications for screening for cervical cancer.
1995 • 75 citations
Epidemiologic Determinants of Seroreactivity to Human Papillomavirus (HPV) Type 16 Virus-Like Particles in Cervical HPV-16 DNA--Positive and --Negative Women
1996 • 74 citations
Seroreactivity to Human Papillomavirus Types 16, 18, 31, and 45 Virus‐Like Particles in a Case‐Control Study of Cervical Squamous Intraepithelial Lesions
1999 • 66 citations
Immunoglobulin-A and -G responses against virus-like particles (VLP) of human papillomavirus type 16 in women with cervical cancer and cervical intra-epithelial lesions
1998 • 47 citations
Aims and background
1997 • 31 citations
Prospective study on cervical neoplasia IV. Presence of HPV antibodies
1999 • 17 citations
Human papillomavirus infection of the female genital tract: correlation of HPV DNA with cytologic, colposcopic, and natural history findings.
1992 • 9 citations
Avoidable cancers in the Nordic countries. Biological agents.
1997 • 3 citations
Viral Load of Human Papilloma Virus 16 as a Determinant for Development of Cervical Carcinoma In Situ: A Nested Case-Control Study
2001 • 3 citations
Biological agents
1997 • 3 citations
Deleted Work
1955 • 0 citations
Cited By (0)
No citing papers found in database